Clinical Guidelines

MENU

Cervical cancer screening

Diagnosis of high-grade squamous abnormalities

Clinical question

GUIDELINE UPDATES - This guideline was last updated 7/1/2022

Background

HSIL may be suspected from the cytological examination of cells from a cervical smear or LBC preparation. However, in Australia it has been considered best practice to establish the final diagnosis on histopathological examination of tissue obtained from cervical punch biopsy or an excisional procedure. 

Histological diagnosis of HSIL (CIN2/3) is necessary before proceeding to treatment, except in certain circumstances. Treatment undertaken at the time of initial colposcopic assessment is known as ‘treatment at first visit’ or ‘see-and-treat’ (see Treatment at first visit in Chapter 7. Colposcopy).

Recommendation

Consensus-based recommendation*
REC10.1: Histological diagnosis prior to treatment
For women who have a visible lesion at colposcopy, histological confirmation of HSIL is recommended before undertaking definitive treatment.

Author(s):

Back to top

WEBSITE UPDATES - This website was last updated 7/1/2022

Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.
Acknowledgement Image Title
Cancer Council Australia